SFI
UTHR icon

Siemens Fonds Invest’s United Therapeutics UTHR Stock Holding History

Siemens Fonds Invest’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Hold
575
– – 0.02% 414
2026
Q1 		$341K Sell
575
-13
-2% -$6.47K 0.02% 379
2025
Q4 		$292K Sell
588
-108
-16% -$50.3K 0.02% 410
2025
Q3 		$292K Buy
696
+3
+0.4% +$1.01K 0.02% 402
2025
Q2 		$199K Buy
693
+100
+17% +$29.9K 0.01% 463
2025
Q1 		$183K Sell
593
-1,390
-70% -$476K 0.01% 443
2024
Q4 		$709K Buy
+1,983
New +$729K 0.05% 252
2024
Q3 		– Sell
-1,723
Closed -$549K – 462
2024
Q2 		$549K Hold
1,723
– – 0.04% 258
2024
Q1 		$396K Buy
+1,723
New +$389K 0.03% 328

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Siemens Fonds Invest's UTHR Position: Q2 2026 in Review

Siemens Fonds Invest held its United Therapeutics (UTHR) position steady in Q2 2026 at 575 shares worth $312K. The position accounts for 0.02% of the portfolio, ranked #414.

Siemens Fonds Invest first reported a position in UTHR in Q1 2024 and has held it in 9 quarters since. The position peaked at $709K in Q4 2024. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Siemens Fonds Invest held 575 shares of United Therapeutics worth $312K as of Q2 2026.
  • Siemens Fonds Invest left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.02% of Siemens Fonds Invest's portfolio in Q2 2026, its #414 holding.
  • Siemens Fonds Invest first reported a position in United Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Siemens Fonds Invest's United Therapeutics position peaked at $709K in Q4 2024.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Siemens Fonds Invest's 13F filing for Q2 2026, filed 14 Aug 2026.